KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
Rumman Chowdhury, ex-director of Twitter's machine ethics team, has strong words for Elon Musk and the Department of ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-yearStrong growth in key commercial metrics, including ...
The White House March 13 withdrew the nomination of former Republican congressman Dave Weldon for director of the Centers for ...
The U.S. Food and Drug Administration’s chief counsel resigned two days after her appointment, according to a Thursday announcement from the agency.  “Hilary K. Perkins has resigned from her ...
Kennedy vowed to “Make America Healthy Again,” has delivered an inconsistent message that has the nation’s top infectious ...
The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a post on ...
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
Recently selected Food and Drug Administration chief lawyer, Hilary K. Perkins, has resigned from the job, according to a post from the FDA on X.  Read More ...
As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.